4 research outputs found

    Microcirculatory Status and Metabolic Activity of Tissues after Local Administration of Autologous Plasma on the Model of Explosive Soft Tissue Wound in Rats

    Get PDF
    Background. The possibility of local application of autologous blood plasma (ABP) in soft tissue injuries is currently of particular interest.Objectives. Evaluation of the effects of peri-wound (perifocal) administration of ABP on red blood parameters, microcirculation and oxygen supply of soft tissues of the limb in experimental explosive wound (EW) in rats.Methods. EW was simulated on male Wistar rats (n=146) using a firecracker with a pyrotechnic mixture (patent RU No. 2741238 dated 22.01.2021). Animals were divided into 4 groups: control (2), comparison (1), main (1). The volume of blood loss in explosive wounds was 8 and 15% of the estimated circulating blood volume (CBV) of the animal. Blood was drawn from the rat tail to obtain ABP. 3 hours after the injury, ABP or 0.9% sodium chloride solution was injected intramuscularly into the explosive wound area at a rate of 2.0 ml/kg of animal weight. After 3, 7, 14, 28 days, the number of red blood cells, haemoglobin content, haematocrit were determined in the blood, and microcirculation and oxidative metabolism parameters were determined in the skeletal muscles of the injured area. The data were processed using Microsoft Excel 2013 (Microsoft, USA) and Statistica 10.0 (StatSoft Inc., USA).Results. Blood loss of 8% of the CBV in injured animals did not lead to changes in the quantitative composition of peripheral red blood. After an explosive wound with a blood loss of 15% of the CBV, there was a moderate decrease in the number of red blood cells (from 8.3Γ—1012/l to 6.5Γ—1012/l, p < 0.02), haemoglobin level (from 149.5 g/l to 118 g/l, p < 0.01), haematocrit (from 43.8% to 33.6%, p < 0.01) with recovery by day 7 of observation. The explosive soft tissue wound was characterized by marked post-traumatic microcirculatory disorders irrespective of the amount of blood loss. Perifocal intramuscular administration of ABP in animals with an explosive wound and blood loss of 15% CBV reduced the severity of post-traumatic microcirculatory and oxidative metabolic disorders mainly in the early post-traumatic period, as evidenced by an increase in the perfusion variation coefficient Kv by 1.2–1.3 times (p < 0.05), tissue oxygen consumption U by 20–22% (p < 0.05) and fluorescent oxygen consumption by FPC by 48% (p < 0.05).Conclusion. With an experimental explosive wound of the soft tissues of the thigh in rats, a single early (3 hours after the injury) peri-wound intramuscular administration of ABP reduces the severity of local post-traumatic microcirculatory and metabolic disorders in skeletal muscle

    The efficiency of replenishment of acute blood loss by an experimental blood substitute comprising human’s umbilical cord blood red blood cells

    Get PDF
    Π’ΠΎ assess the effectiveness of the experimental blood substitute containing erythrocytes of human umbilical cord blood, were analyzed the dynamics of indicators of cardiovascular and respiratory systems, quantitative indicators of red blood, the severity of hemolysis in dogs within 24 hours after equivalent replenishment of acute blood loss for about 50% of the volume of circulating blood. The comparative drug was the adult human packed RBCs, used in clinical practice. It was found that after replenishment of blood loss in dogs, hemolytic anemia developed less pronounced after transfusion of the blood substitute with erythrocytes of human umbilical cord blood. Indicators of cardiovascular and respiratory systems were restored to the baseline in 24 hours after replenishment of acute blood loss by an experimental blood substitute with human umbilical cord blood erythrocytes with persistent changes after transfusion of the adult human packed RBCs. The relatively higher efficiency of the experimental blood substitute is due to the structural and functional stability of erythrocytes in the umbilical cord blood. A conclusion was made about the prospects of development of blood substitutes-oxygen carriers containing human umbilical cord blood erythrocytes.Π‘ Ρ†Π΅Π»ΡŒΡŽ ΠΎΡ†Π΅Π½ΠΊΠΈ эффСктивности ΡΠΊΡΠΏΠ΅Ρ€ΠΈΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ кровСзамСнитСля, содСрТащСго эритроциты ΠΏΡƒΠΏΠΎΠ²ΠΈΠ½Π½ΠΎΠΉ ΠΊΡ€ΠΎΠ²ΠΈ Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ°, ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ сСрдСчно-сосудистой ΠΈ Π΄Ρ‹Ρ…Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠΉ систСм, количСствСнных ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ красной ΠΊΡ€ΠΎΠ²ΠΈ, выраТСнности Π³Π΅ΠΌΠΎΠ»ΠΈΠ·Π° Ρƒ собак Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ 24 часов послС восполнСния острой ΡΠΊΡΠΏΠ΅Ρ€ΠΈΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½ΠΎΠΉ ΠΊΡ€ΠΎΠ²ΠΎΠΏΠΎΡ‚Π΅Ρ€ΠΈ ΠΎΠΊΠΎΠ»ΠΎ 50% ΠΎΡ‚ объСма Ρ†ΠΈΡ€ΠΊΡƒΠ»ΠΈΡ€ΡƒΡŽΡ‰Π΅ΠΉ ΠΊΡ€ΠΎΠ²ΠΈ. ΠŸΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠΌ сравнСния слуТила эритроцитарная масса Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ°, ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΠ΅ΠΌΠ°Ρ Π² клиничСской ΠΏΡ€Π°ΠΊΡ‚ΠΈΠΊΠ΅. УстановлСно, Ρ‡Ρ‚ΠΎ послС восполнСния ΠΊΡ€ΠΎΠ²ΠΎΠΏΠΎΡ‚Π΅Ρ€ΠΈ Ρƒ собак Ρ€Π°Π·Π²ΠΈΠ²Π°Π»Π°ΡΡŒ гСмолитичСская анСмия, ΠΌΠ΅Π½Π΅Π΅ выраТСнная послС трансфузии кровСзамСнитСля с эритроцитами ΠΏΡƒΠΏΠΎΠ²ΠΈΠ½Π½ΠΎΠΉ ΠΊΡ€ΠΎΠ²ΠΈ Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ°. ΠŸΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ Π΄Π΅ΡΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΠΈ сСрдСчно-сосудистой ΠΈ Π΄Ρ‹Ρ…Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠΉ систСм Π²ΠΎΡΡΡ‚Π°Π½Π°Π²Π»ΠΈΠ²Π°Π»ΠΈΡΡŒ Π΄ΠΎ исходного уровня Ρ‡Π΅Ρ€Π΅Π· 24 часа послС восполнСния ΠΊΡ€ΠΎΠ²ΠΎΠΏΠΎΡ‚Π΅Ρ€ΠΈ ΡΠΊΡΠΏΠ΅Ρ€ΠΈΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½Ρ‹ΠΌ ΠΊΡ€ΠΎΠ²Π΅Π·Π°ΠΌΠ΅Π½ΠΈΡ‚Π΅Π»Π΅ΠΌ с эритроцитами ΠΏΡƒΠΏΠΎΠ²ΠΈΠ½Π½ΠΎΠΉ ΠΊΡ€ΠΎΠ²ΠΈ Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ° ΠΏΡ€ΠΈ ΡΠΎΡ…Ρ€Π°Π½ΡΡŽΡ‰ΠΈΡ…ΡΡ измСнСниях послС вливания эритроцитарной массы Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ°. Π‘Ρ€Π°Π²Π½ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎ Π±ΠΎΠ»Π΅Π΅ высокая ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ ΡΠΊΡΠΏΠ΅Ρ€ΠΈΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ кровСзамСнитСля ΠΎΠ±ΡŠΡΡΠ½ΡΠ΅Ρ‚ΡΡ структурно-Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠΉ ΡΡ‚Π°Π±ΠΈΠ»ΡŒΠ½ΠΎΡΡ‚ΡŒΡŽ эритроцитов ΠΏΡƒΠΏΠΎΠ²ΠΈΠ½Π½ΠΎΠΉ ΠΊΡ€ΠΎΠ²ΠΈ. Π‘Π΄Π΅Π»Π°Π½ΠΎ Π·Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅ ΠΎ пСрспСктивности Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΠΈ ΠΊΡ€ΠΎΠ²Π΅Π·Π°ΠΌΠ΅Π½ΠΈΡ‚Π΅Π»Π΅ΠΉ-пСрСносчиков кислорода, содСрТащих эритроциты ΠΏΡƒΠΏΠΎΠ²ΠΈΠ½Π½ΠΎΠΉ ΠΊΡ€ΠΎΠ²ΠΈ Ρ‡Π΅Π»ΠΎΠ²Π΅ΠΊΠ°
    corecore